Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Primate TRAIL/TNFSF10 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB3751500
This item is not returnable.
View return policy
Description
TRAIL/TNFSF10 Monoclonal specifically detects TRAIL/TNFSF10 in Human, Primate samples. It is validated for ELISA Capture (Matched Antibody Pair).Specifications
| TRAIL/TNFSF10 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Apo-2 ligand, APO2L, Apo-2Ltumor necrosis factor (ligand) family, member 10, APO2Ltumor necrosis factor apoptosis-inducing ligand splice variant delta, CD253, CD253 antigen, Protein TRAIL, TL2, TNF-related apoptosis-inducing ligand, TNFSF10, TRAILTNF-related apoptosis inducing ligand TRAIL, tumor necrosis factor (ligand) superfamily, member 10, tumor necrosis factor ligand superfamily member 10 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 8743 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| ELISA | |
| 124723 | |
| ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
| P50591 | |
| TNFSF10 | |
| E. coli-derived recombinant human TRAIL Val114-Gly281 Accession # P50591 | |
| 500 μg | |
| Primary | |
| Detects human and primate TRAIL in direct ELISAs. | |
| Human, Primate | |
| Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction